MODE OF DRUG DEGRADATION

Views:
 
Category: Education
     
 

Presentation Description

No description available.

Comments

Presentation Transcript

MODE OF DRUG DEGRADATION:

MODE OF DRUG DEGRADATION ANAND PHARMACY COLLEGE PREPARED BY :- DHRUV BHAVSAR MPHARM P’CEUTICS

INTRODUCTION:

INTRODUCTION Food is spoiled by three varieties of decomposition; physical, chemical and microbiological. “more processing- less stable”; “more contact with water – less stable”. All this is true for drugs also. Pure drugs, solids, liquids, or gases are usually more stable than their formulations. When they are formulated into medicines decomposition happens faster because of the presence of excipients, and moisture and because of processing.

TYPES OF DRUG DEGRADATION:

TYPES OF DRUG DEGRADATION CHEMICAL DEGRADATION HYDROLYSIS ESTER AMIDES BARBITURATES, HYDANOINS & IMIDES SCHIFF BASE AND OTHER REACTION INVOLVING CARBON NITROGEN BOND CLEAVAGE DEHYDRATION ISOMERIZATION & RACEMIZATION DECARBOXYLATION & ELIMINATION OXIDATION PHOTODEGRADATION

Slide 4:

Drug-Excipientand Drug-Drug Interactions Reactions of Bisulfite, an Antioxidant Reaction of Amines with Reducing Sugars Transesterification Reactions PHYSICL DEGRADATION CRYSTALIZATION OF AMORPHOUS DRUGS TRANSITION IN CRYSTALINE STATE FORMATION & GROWTH OF CRYSTAL VAPOUR PHASE TRANFER INCLUDING SUBLIMATION MOINSTURE ADSORPTION MICROBIAL DEGRADATION

HYDROLYSIS :

HYDROLYSIS Drugs with functional groups such as esters, amides, lactones or lactams may be susceptible to hydrolytic degradation. It is probably the most commonly encountered mode of drug degradation because of the prevalence of such groups in medicinal agents and the ubiquitous nature of water. Water can also act as a vehicle for interactions or facilitate microbial growth.

ESTER HYDROLYSIS :

ESTER HYDROLYSIS The degradation rate depends on the substituents R1 and R2, in that electron-withdrawing groups enhance hydrolysis whereas electron-donating groups inhibit hydrolysis Another way of viewing this reaction is by considering leaving-group ability. Bulky groups on either R1 or R2 decrease the decomposition rate..

Slide 7:

EXAMPLES Cocaine has two ester bonds that hydrolyze to produce benzoylecgonine or ecgonine methyl ester . Lactones, or cyclic esters pilocarpine, dalvastatin and warfarin undergoes hydrolysis due to ring opening.

AMIDES HYDROLYSIS :

AMIDES HYDROLYSIS Amide bonds are commonly found in drug molecules. Amide bonds are less susceptible to hydrolysis than ester bonds because the carbonyl carbon of the amide bond is less electrophilic (the carbon-to-nitrogen bond has considerable double bond character) The leaving group, an amine, is a poorer leaving group

Slide 9:

EXAMPLES Acetaminophen, chloramphenicol,lincomycin, indomethacin and sulfacetamide, all of which are known to produce an amine and an acid through hydrolysis of their amide bonds. β-Lactam antibiotics such as penicillins and cephalosporins, which are cyclic amides or lactams, undergo rapid ring opening due to hydrolysis.

BARBITURATES, HYDANTOINS & IMIDES :

BARBITURATES, HYDANTOINS & IMIDES Barbiturates, hydantoins, and imides contain functional groups related to amides but tend to be more reactive. Barbituric acids such as barbital, phenobarbital and amobarbital, undergo ring-opening hydrolysis. Decomposition products formed from these drug substances are susceptible to further decomposition reactions such as decarboxylation.

Slide 11:

SCHIFF BASE AND OTHER REACTION INVOLVING CARBON NITROGEN BOND CLEAVAGE Benzodiazepines such as diazepam,oxazepam, and nitrazepam undergo ring opening due to reversible hydrolysis of the amide and azomethine bonds Benzodiazepinoxazoles(oxazole-condensed benzodiazepines) such as oxazolam,flutazolam, haloxazolam, and cloxazolam are not Schiff bases but undergo ring opening due to hydrolysis.

DEHYDRATION :

DEHYDRATION Sugars such as glucose and lactose are known to undergo dehydration to form 5-( hydroxymethyl ) furural . Erythromycin is susceptible to acidcatalyzed dehydration. prostaglandins E1 and E2 undergo dehydration followed by isomerization . Batanopride undergoes an intramolecular ring-closure reaction in the acidic pH range due to dehydration whereas streptovitacin A exhibits two successive acid-catalyzed dehydration reactions,.

ISOMERIZATION :

ISOMERIZATION isomerisation is the process by which one molecule is transformed into another molecule which has exactly the same atoms, but the atoms are rearranged e.g. A-B-C → B-A-C Pilocarpine undergoes epimerization by base catalysis. Tetracyclines such as rolitetracycline and ergotamine exhibit epimerization by acid catalysis. Etoposide converts reversibly to picroetoposide , a cis -lactone , and then hydrolyzes to cis-hydroxy acid in the alkaline pH region.

RACEMIZATION :

RACEMIZATION Racemization refers to partial conversion of one enantiomer into another. Epinephrine is oxidized and undergoes racemization under strongly acidic conditions.

DECARBOXYLATION :

DECARBOXYLATION Drug substances having a carboxylic acid group are sometimes susceptible to decarboxylation, 4-Aminosalicylic acid is a good example. Foscarnet also undergoes decarboxylation under strongly acidic conditions,

ELIMINATION:

ELIMINATION In elimination reaction reaction some groups of the substance is eliminated. Trimelamol eliminates its hydroxymethyl groups and forms formaldehyde. Levothyroxine eliminates iodine.

OXIDATION:

OXIDATION Oxidation mechanisms for drug substances depend on the chemical structure of the drug and the presence of reactive oxygen species or other oxidants. Catechols such as methyldopa and epinephrine are readily oxidized to quinones.

PHOTODEGRADATION:

PHOTODEGRADATION Photodegradation is the process by which light-sensitive drugs or excipient molecules are chemically degraded by light, room light or sunlight. The variation of degradation depends on the wavelength of light, shorter wavelengths because more damage than longer wavelengths . Before a photodegradation reaction can occur, the energy from light radiation must be absorbed by the molecules. Photodegradation of the chloroquine and primaquine gives the various product through different pathways.

Slide 19:

Two way in which photodegradation can occur are: the light energy absorbed must be sufficient to achieve the activation energy or the light energy absorbed by molecules is passed on to other molecules which allow degradation to take place. Representative photodegradation routes for drug substances include dehydrogenation of nifedipine , dehydrogenation accompanied by transmutation of a nitro group in nimodipine observed. Representative photodegradation routes for drug substances include dehydrogenation of nifedipine , dehydrogenation accompanied by transmutation of a nitro group in nimodipine observed.

DRUG-EXCIPIENT & DRUG-DRUG INTERACTION:

DRUG-EXCIPIENT & DRUG-DRUG INTERACTION drugs are rarely formulated as just the drug substance itself. Often, additives or excipients are present in the formulation. Quite often, reactions can occur between the drug and one or more additives. Similarly, two drugs might be formulated in the same product and react with each other.

REACTION OF BISULPHITE, AN ANTIOXIDANT:

REACTION OF BISULPHITE, AN ANTIOXIDANT epinephrine, a catecholamine, undergoes displacement of its hydroxy group by bisulfite. Dexamethasone 21-phosphate, an α/β-unsaturated ketone, is known to undergo addition by bisulfite.

REACTION OF AMINES WITH REDUCING SUGARS:

REACTION OF AMINES WITH REDUCING SUGARS Reducing sugars readily react with primary amines, including those of amino acids, through the Maillard reaction. Drug substances with primary or secondary amine groups undergo this addition/rearrangement reaction, also called the .browning. reaction because of the resulting discoloration

Slide 24:

Examples are the reaction of amphetamine,isoniazid dextroamphetamine sulfate and norphenylephrine with sugars such as lactose and the degradation products of sugars, such as 5-(hydroxymethyl)furfural. Sulpyrine forms ann addition product with glucose

TRANSESTERIFICATION REACTION:

TRANSESTERIFICATION REACTION In the presence of drug substances with hydroxy groups, aspirin undergoes a reversible transacylation reaction to form salicylic acid, while acetylating the drug substance. For example, codeine and sulfadiazine are acetylated by aspirin Similar acetylation reactions with aspirin have been reported for acetaminophen and the excipient polyethylene glycol.

BASIC KINETIC PRINCIPLE:

BASIC KINETIC PRINCIPLE The simplest concept of chemical and physical reaction is the case of a drug D reacting to form a product P. This process is described by the following scheme The extent to which D rearranges to P will depend on the free-energy differences between D and P. If P is of much lower free energy than D, then the reaction is better defined by

Slide 28:

Most drugs degrade by reactions that involve a so-called bimolecular reaction in which drug D collides with a reactant A to produce one or more products. This is illustrated in its simplest form by the following equation: the rate of loss of D,- d[D]/dt, is said to be proportional to the activity

Slide 29:

When the proportionality constant is included, the following equation is obtained: where k is the proportionality constant, usually referred to as the rate constant. If k is large, the reaction is fast; if k is small, the reaction is slow. In this case, the reaction rate (-d[D]/d t ) is said to be frrst-order in D and first-order in A.

Slide 30:

If A is present in excess of D, that is, [A] >> [D], then even though some of A is consumed during the reaction, effectively only D is lost. Under these circumstances where kobs is said to be the observed rate constant, a pseudo-first-order constant. In most studies of the stability of pharmaceuticals, especially in aqueous solution, the kinetics can often be simplified to pseudo-fist-order conditions

Kinetic Models to Describe Drug Degradation:

Kinetic Models to Describe Drug Degradation The generalized rate expression for drug degradation is represented by the rate equation. When a drug substance, D, degrades via a certain mechanism in which reactants A, B, . . . participate, the degradation rate generally depends on the concentrations of the various reactants A, B, . . . and D according to , assuming that all the reactants are involved directly or indirectly in the rate-controlling step.

Simple Pseudo-First-Order Reaction:

Simple Pseudo-First-Order Reaction The differential rate equation for a pseudo-first-order reaction is The integrated form of this equation is where [D]0 is the initial concentration of the drug. From these equations, the degradation rate is seen to be proportional to drug concentration. Most drug degradation kinetics in solutions like syrup and elixir conform to apparent or pseudo-first-order kinetics

PSEDO ZERO ORDER REACTION:

PSEDO ZERO ORDER REACTION The rate equations for pseudo-zero-order kinetics are In this case, the drug degradation rate is independent of drug concentration. A specific example of pseudo-zero-order kinetics can be seen with drug degradation in suspensions

Slide 34:

Time course of degradation of aspirin in suspension (pH 3.0), showing apparent zero-order behavior and a dependency on temperature but no dependency on particle size. Particle size: , 60 mesh; O, 100 mesh.

PSEUDO FIRST ORDER REVERSIBLE REACTION:

PSEUDO FIRST ORDER REVERSIBLE REACTION When drug D converts to product P according to reversible pseudo-first-order reactions, the rate is described by following equation Hydrolysis of triazolam and racemization of oxazepam conform to this kinetic model,

Slide 36:

Time course of formation of triazolam from its hydrolysis product (pH 2.30, 37°C).

Slide 37:

Time course of racemization of oxazepam

Pseudo second and pseudo first order reversible reaction:

Pseudo second and pseudo first order reversible reaction When drug D reacts reversibly with A to form P according to a pseudo-second-orderm reaction, the rate expression for the loss of D is given by Interaction of Isoniazid with reducing sugar follow this type of model

Slide 39:

Time course of reaction of isoniazid with various reducing sugars under second-order reaction conditions (pH 1.8, 37°C). , Galactose; X, lactose; O, glucose; Δ, maltose .

Pseudo First and pseudo second order reversible reaction:

Pseudo First and pseudo second order reversible reaction Equation represents the rate of reversible conversion of drug D to products P1 and P2. When [P1]0 = [P2]0 = 0 at t = 0, Eq. can be integrated to give Eq. The loss of hydrochlorothiazide follows this model

Pseudo first order consecutive reaction:

Pseudo first order consecutive reaction Equations and represent the case when drug D converts to P1, which is subsequently converted to P2 according to consecutive pseudo-fist-order reactions A good example of consecutive reactions is the degradation of carmethizole (NSC-602668), an experimental cytotoxic agent The hydrolysis of hydrocortisone hemisuccinate fit this mathematical model even though their degradation pathways are more complex.

Slide 42:

Time course of hydrolysis of hydrocortisone hemisuccinate

Pseudo-FirstOrder Reversible and Parallel Reactions:

Pseudo-FirstOrder Reversible and Parallel Reactions When both P1 and P2 are capable of being converted back to D, Eqs . and adequately describe the kinetics. Degradation of pilocarpine in the neutral pH region appears to conform to this model

Slide 44:

Time course of degradation of pilocarpine

Pseudo-First-Order Reversible, Parallel and Consecutive Reactions:

Pseudo-First-Order Reversible, Parallel and Consecutive Reactions When the P1 is in equilibrium with D After Integration the Equation becomes

Slide 46:

Isomerization and hydrolysis of chlorphenesin carbamate under strongly alkaline pH condition and epimerization and hydrolysis of carumonam and moxalactam all appear to conform to this model. Hydrolysis of chlorothiazide, under alkaline pH conditions, is explained by this model when k3 is set to zero

Slide 47:

Time courses of epimerization and hydrolysis of cazumonam

Slide 48:

Time course of hydrolysis of chlorothiazide

Pseudo-First- and Pseudo-Second-Order Parallel Reactions:

Pseudo-First- and Pseudo-Second-Order Parallel Reactions When a reaction pathway involves toth pseudo-fist and pseudo-second-order pathways, and the following equation adequately describe the kinetics Degradation of Ampicillian follow this Pathway.

Slide 50:

Time course of degradation of ampicillin

Equilibriam pseudo first order parallel reaction:

Equilibriam pseudo first order parallel reaction This case obtains when a drug, D, forms a complex (DA) with A, which is defined by the equilibrium constant, K, and both D and DA are capable of undergoing independent pseudo-first-order reactions. When the concentration of A is significantly higher than that of D, the kinetics can be described by Eq

Slide 52:

The degradation of carbenicillin in the presence of human serum albumin1 follows this Model

Crystallization of Amorphous Drugs:

Crystallization of Amorphous Drugs Attempts are often made to formulate poorly water-soluble drugs in their amorphous state. This is because the solubility of amorphous materials is generally higher than that of the same substances in their crystalline state. However, because of the lower free energy of the crystalline state, amorphous substances tend to change to their more thermodynamically stable crystalline state with time. Amorphous nifedipine, coprecipitated with polyvinylpyrrolidone, undergoes partial crystallization during storage under high-humidity conditiods. This change resulted in altered dissolution and solubility behavior,

Slide 54:

Oxyphenbutazone, which can exist in an amorphous state and three different crystalline states (anhydrous, monohydrate, and hemihydrate), exhibits crystallization and polymorphic transitions during storage depending on humidity, as illustrated in Scheme.

Transitions in Crystalline States:

Transitions in Crystalline States Polymorphs are different crystalline forms of the same drug. Because these forms have different free energy or chemical potentials, depending on temperature conditions, transitions between polymorphs occur. Polymorphic transitions during storage may alter critical properties of drugs because the solubility and dissolution rate of drug substances generally vary with changes in their crystalline form. From a storage perspective, temperature and humidity affect polymorphic transitions. Transitions between anhydrous and hydrated forms have been reported for many drug substances such as raclopride, theophylline, nitrofurantoin, sulfaguanidine, and phenobarbital.

Slide 56:

Cianidanol exhibits polymorphic transitions between seven different crystalline forms, depending on temperature and humidity

Formation and Growth of Crystals:

Formation and Growth of Crystals Molecules in a crystal, and the crystals themselves, should not be considered static. Crystals can grow or decrease in size provided that there is a medium across which the molecules can travel. This could be a liquid phase or a gaseous phase into which the molecules can sublime. For example, drug substances and excipients in solid dosage forms, such as tablets and granules, may recrystallize or sublime onto the surface of the dosage form during storage. So-called .whisker. Crystallization was observed in tablets of ethenzamide and caffeine anhydride. This crystallization was enhanced in porous tablets and at higher temperatures

Slide 58:

Whisker formation in ethenzamide tablets conformed to apparent zero-order kinetics, and the rate constant followed Arrhenius behavior in the temperature range 20.65°C. Particles of a valproate-synthetic aluminum silicate mixture formed whiskers comprised of valproic acid and sodium valproate (1:1) on their surface. Carbamazepine tablets containing stearic acid formed column-shaped crystals on the tablet surface during storage at high temperature

Vapor-Phase Transfers Including Sublimation:

Vapor-Phase Transfers Including Sublimation Pharmaceuticals containing components that sublime easily may undergo changes in drug content owing to the sublimation of the drug substances or excipients. In the case of nitroglycerin, which is a liquid with a significant vapor pressure, sublingual tablets exhibited significant variations in drug content during storage owing to intertablet migration through the vapor phase, This transfer was inhibited by adding water-soluble, nonvolatile fixing agents such as polyethylene glycol.

Moisture Adsorption:

Moisture Adsorption Moisture adsorption during storage can also affect the physical stability of pharmaceuticals, leading to changes in such properties as appearance and dissolution rate. Adsorption of moisture is governed by the physical properties of the drug substance and excipients. For example, the adsorption of moisture by aspirin crystals was enhanced by adding hydrophilic excipients. Zografi and co-workers reported that the moisture adsorption rate, W´, for water-soluble substances can be represented by the following equations, based on a heattransport control model

Slide 61:

RHi and RH0 are relative humidity and critical relative humidity, respectively, and C and F are the conductive coefficient and the radiative coefficient, respectively. The above equation described the adsorption of moisture by a sucrose-potassium bromide mixture.

Microbial degradation:

Microbial degradation Contamination of a product may sometimes cause a lot of damage and sometimes may not be anything at all. Thus it is dependent on the type of microbe and its level of toxicity it may produce. If parenterals or opthalmic formulations are contaminated, it may cause serious harm. Pyrogens which are the metabolic products of bacterial growth are usually lipo-polysaccharides and they represent a particularly hazardous product released by gram negative bacteria . If administered inadvertently to a patient they may cause chills and fever.

Prevention of microbial spoilage :

Prevention of microbial spoilage A preservative has to be used thus it must have the require oil/water partition coefficient, it must be non-toxic, odourless, stable and compatible with other formulation components while exerting its effects.

Methods for Detecting Chemical and Physical Degradation:

Methods for Detecting Chemical and Physical Degradation Critical for good studies involving the analysis of drugs and their degradants is the establishment and validation of so-called .stability indicating methods. These methods are. Thermal Analysis method Differential scanning calorimetry (DSC), differential thermal analysis (DTA), and differential thermogravimetry (DTG) Diffuse Reflectance Spectroscopy

Thermal analysis:

Thermal analysis Differential scanning calorimetry (DSC), differential thermal analysis (DTA), and differential thermogravimetry (DTG) are very useful in formulation screening because calorimetric changes and weight changes caused by chemical and physical degradation of pharmaceuticals can be readily detected. DSC was employed in the preformulation study of a poorly water-soluble drug substance, α -pentyl-3-(2-quinolinylmethoxy) benzenemethanol (REV5901). Thermal analysis is often capable of easily detecting drug-excipient interactions.

Slide 66:

For example, accelerated degradation of aspirin caused by physical mixture with silica and aluminum was detected by DSC. Interaction of ibuprofen with magnesium oxide was detected from changes in DSC thermograms DSC can also be employed to investigate the stability of finished dosage forms, as was done, for example, with aminophylline suppository formulation. The kinetics of degradation can be studied using isothermal calorimetry, that is, calorimetry performed at constant temperature.

Slide 67:

Recently, sensitive thermal conductivity microcalorimeters useful for detecting even small amounts of degradation at room temperature have become available. For example, the slow solid-state degradation of cephalosporins at a rate of approximately 1% per year was successfully measured by microcalorimetry.

Diffuse Reflectance Spectroscopy:

Diffuse Reflectance Spectroscopy Diffuse reflectance spectroscopy was employed to detect the solid-state interactions between various drug substances such as oxytetracycline and various excipients such as magnesium trisilicate. The DRS spectrum of an isoniazid-magnesium oxide mixture exhibited a decrease in reflectance r∞ with increasing isoniazid content. The remission function, calculated by the Kubelka-Munk equation was proportional to isoniazid content.

Slide 69:

Thus, the solid-state degradation could be followed quantitatively by DRS. A difficulty with technique, especially when performed at short wavelengths, is spectral interference from the degradation products. DRS is especially useful for detecting small changes occurring locally on solid surfaces.

Stabilization of Drug Substances against Chemical Degradation:

Stabilization of Drug Substances against Chemical Degradation Stabilization by Modification of Molecular Structure of Drug Substances Stabilization by Complex Formation Stabilization by the Formation of Inclusion Complexes with Cyclodextrins Stabilization by Incorporation into Liposomes, Micelles, or Emulsions Addition of Stabilizers Such as Antioxidants and Stabilization through the Use of Packaging

Stabilization by Modification of Molecular Structure of Drug Substances :

Stabilization by Modification of Molecular Structure of Drug Substances Drug degradation rates depend on the chemical structure of the drug. Most often, structure modifications are performed to enhance activity or to have a positive impact on the in vivo properties of the drug. An example of analog development to effect stabilization is the masking of reactive hydroxyl groups. Degradation of erythromycin via 6,9-hemiketal breakdown under acidic pH conditions is inhibited by substituting a methoxy group for the C-6 hydroxyl. For example, the acid stability of clarithromycin is 340 times greater than that of erythromycin.

Stabilization by Complex Formation :

Stabilization by Complex Formation Complex formation between drugs and excipients often leads to stabilization of drugs. The forces involved in complex formation include van der Waals forces, dipole.dipole interactions, hydrogen bonding,and hydrophobic interactions . If drug D forms a complex with ligand L, the complex (assuming a 1 : 1 interaction) can be defined by a complexation constant K.

Slide 73:

The term [D.L] represents the concentration of the complex, D.L, [D]. is the concentration of free or uncomplexed drug, and [L]. is the concentration of free ligand. Kf represents the rate constant for the degradation of the drug in the absence of complexation, and k, is the rate constant for the degradation of the drug in its complexed form. As can be seen, the drug will be stabilized by the presence of L if kc < k.. The degree of stabilization will also depend on the relative amounts of free and complexed drug, which in turn depends on the concentrations of D and L and the magnitude of K. Conversely,

Slide 74:

if kc > k., complex formation will result in acceleration of the degradation. Differing ligands (L) in a series can affect the degradation rate in two ways: first, by affecting the degree of complexation, as measured by K, and, second, by affecting kc. Ampicillin, cephalexin, and bacampicillin are stabilized by complex formation with aldehydes such as benzaldehyde and furfural, although this stabilization involves reversible formation of covalent species. Stabilization of esters such as benzocaine (Fig. 120), procaine, and tetracaine by complex formation with caffeine .

Stabilization by the Formation of Inclusion Complexes with C yclodextrins:

Stabilization by the Formation of Inclusion Complexes with C yclodextrins Cyclodextrins are nonreducing cyclic oligosaccharides, consisting of six (α -(CD), seven (β -CD), or eight (γ -CD) dextrose units. Cyclodextrins have a .doughnut. shape, with the interior of the molecule being relatively hydrophobic and the exterior being relatively hydrophilic. Because of their unique chemical structure, cyclodextrins are capable of forming so-called .inclusion. complexes with many drug molecules. The natural cyclodextrins, α − , β −, and γ -CD, have been chemically modified either to effect stronger complexation or to improve their safety

Slide 76:

α -CD and β -CD cannot be used parenterally because of their nephrotoxicity. For example, Hydrolysis of bencyclane fumarate is inhibited by α −, β −, and γ –CD.

Stabilization by Incorporation into Liposomes, Micelles, or Emulsions:

Stabilization by Incorporation into Liposomes, Micelles, or Emulsions Entrapment of drug substances in liposomes and micelles can lead to changes in their stability. Aspirin can be partially stabilized by incorporation in L- α -dimyristoylphosphatidylcholine (DMPC)-based liposomes. Anesthetics such as procaine are also stabilized by incorporation in liposomes. Physostigmine salicylate in a phospholipid emulsion is stabilized through interaction with phospholipids at the oil.water interface and through incorporation into the internal phase of the emulsion.

Addition of Stabilizers Such as Antioxidants and Stabilization through the Use of Packaging:

Addition of Stabilizers Such as Antioxidants and Stabilization through the Use of Packaging the effect of oxygen can be eliminated by the addition of antioxidants. Oxidation of lovastatin in aqueous solution is inhibited by antioxidants such as α -tocopherol and butylated hydroxyanisole (BHA). Pharmaceuticals are often stabilized by the utilization of packaging containing an antioxidant. For example, the photooxidation of cianidanol in the solid state was inhibited by lowering the concentration of oxygen with the use of an oxygen absorbent. The use of photoprotective films generally eliminates the effect of light.

Slide 79:

a film coating containing oxybenzone inhibited coloration and photolytic degradation of sulfisomidine tablets. Titanium dioxide in a gelatin capsule shell stabilized indomethacin. Incorporation of synthetic iron oxides resulted in the stabilization of uncoated tablets of nifedipine and sorivudine against phododegradation.

THANK YOU :

THANK YOU